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MaSo far, the digitization of health care is best exempliﬁed by electronic medical records, which have been far from
favorably or uniformly accepted. However, properly implemented digitization can enable better patient outcomes,
improve convenience, potentially lower healthcare costs, and possibly lead to much greater physician satisfaction.
Precision (also known as personalized or individualized) medicine is frequently discussed today, but, in reality, it is what
physicians have attempted to do as best they could for millennia. But now we have new tools that can begin to give us a
much more high-deﬁnition view of our patients; from affordable and rapid genetic testing to wearable sensors that track
a wide range of important physiologic parameters continuously. Although seemingly counterintuitive, the digitization of
health care can also markedly improve the physician-patient relationship, allowing more time for human interaction when
care is bolstered by digital technologies that better individualize diagnostics and treatments. (J Am Coll Cardiol
2015;66:1489–96) © 2015 by the American College of Cardiology Foundation.Digitalization: the administration of digitalis in
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maintain optimal therapeutic concentrations of
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Digitization: the process of changing data into
a digital form that can be easily read and
processed by a computer (2).
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ABBR EV I A T I ON S
AND ACRONYMS
BP = blood pressure
ECG = electrocardiogram
EHR = electronic health record
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1490information, and from this newly generated
information can come greater knowledge of
diseases and treatments.
The objective of this paper is not to provide
a comprehensive summary of the ﬁeld of dig-
ital medicine and the many real challenges totransforming ideas and innovations into clinical re-
ality. For this, we recommend several recent compre-
hensive reviews (4–7). Rather, our goal is to provide a
review of the evidence supporting where digitization
can potentially have the greatest impact, and a vision
for what this could mean for patients and providers.
A HYPOTHETICAL CASE STUDY
Imagine that your clinic is about to begin. You sit down
with your tablet computer and review your ﬁrst pa-
tient’s record. He is a 64-year-old man who you ﬁrst
met over 3 years ago, when he was hospitalized for a
non–ST-segment elevation myocardial infarction. He
also has a long history ofwell-controlled hypertension,
thanks, in part, to genome-guided therapy and routine
24/7 blood pressure (BP) tracking. Although you have
only seen him once since that hospitalization, a quick
look at the summary section of his health record shows
that he has been well cared for in all aspects of risk
factor management, including behavior modiﬁcation.
A simple graph clearly summarizes the average daily
ﬂuctuations in his BP, along with its relationship to his
measured stress levels, sleep, activity, and diet. You
note that he is routinely maintaining excellent activity
levels, is taking all of his prescribedmedications 97%of
days, and that his weight is stable and cholesterol
levels excellent. In fact, everything looks so good that
you begin to wonder why he has asked to see his
cardiologist, rather than just continuewith his primary
healthcare team (centered at his local pharmacy, with
mostly virtual visits).
But, as you scan down to the computer-generated
history of present illness (which your patient was
guided through in a symptom-speciﬁc manner), you
note that he has recently developed some infrequent
chest discomfort, which concerns him, and he would
like to discuss this with you. As you bring him back
into the examination room to build uponwhat you just
read of his history, you take out your handheld ultra-
sound and smartphone electrocardiogram (ECG) to
assure that his echocardiogram and ECG will be auto-
matically populated into the electronic health record
(EHR) and, simultaneously, into the patient’s personal
cloud. You discuss his symptoms, perform a physical
examination, and share your assessment. All the
while, voice recognition software has been expertly
populating a detailed and accurate clinic note. About30 min into the appointment, you begin to develop a
plan in collaboration with your patient. Supported by
automated clinical decision support (which concurs
with your conclusion of a noncardiac etiology with
98% certainty, but also supplies you with the expected
false positive rates of potential functional studies),
you discuss the pros and cons of various next steps in
depth, using a wide range of accumulated individual
data, such as his imaging radiation exposure history
and genome sequence, to together decide on a plan
(Central Illustration).
IS THIS A REALISTIC POSSIBILITY? As unlikely as it
is that this scenario might reﬂect anything even close
to your own clinical experience, that is not due to a
lack of the technology or ability to achieve it. The
tools are available to enable routine care like this; the
kind of care that can drive better patient outcomes
and improved convenience, substantially lowering
healthcare costs, and, in the process, provide much
greater physician satisfaction.
As the case shows, digitization of care is much more
far-reaching than just the institution of EHRs, which,
more often than not, generate anger and frustration
because they are designed primarily to improve
billing, without a signiﬁcant focus on improving either
patient care or physician management (8). However,
true patient-centric digitization of health care can
take advantage of the remarkable strides in technol-
ogy of the last several decades to completely reengi-
neer how care is provided, with the ability to more
effectively individualize patient care and markedly
improve the efﬁciency of medical practice.
INDIVIDUALIZING PATIENT CARE
Population-based data has been the foundation of
medical practice for millennia. The population base of
the earliest medical practitioners was restricted to
their personal experience, and possibly that of their
instructors. Over time, clinical trials were devised to
guide therapies. This eventually led to the ﬁrst ran-
domized controlled trial in 1946, ushering in a new age
of evidence-based practice (9). Thanks to randomized
controlled trials, we have been able to improve our
treatments of a multitude of conditions, or, more
precisely, populations of individuals with those con-
ditions. But we know too well that every patient is
different, and often what works for 1 patient with a
speciﬁc phenotype (e.g., essential hypertension)
doesn’t work in another. We currently do “trial-and-
error” medicine to ﬁnd the right drug to treat each
patient’s hypertension.
HARNESSING GENETIC DATA. The greatest barrier to
better individualizing treatment has been the lack of
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variability within various disease categories. New
tools have rapidly emerged that give us a high-
deﬁnition view of our patients (10). Whole-genome
sequencing is now possible for <$2,000 compared
with the original cost of $3 billion just over 10 years ago.
Although genetic testing has yet to achieve the
revolutionary, across-the-board changes in the diag-
nosis and treatment of most human diseases that were
initially anticipated (11), there have been some truly
remarkable advances (12). For example, a recent
analysis involving nearly 50,000 individuals with or at
risk for coronary disease found a genetic risk score not
only was predictive of the risk of incident or recurrent
coronary disease, but also was able to identify those
who derived the greatest beneﬁt and those who
received no beneﬁt from statin therapy (13). If the data
were more routinely available, pharmacogenomic in-
formation could potentially help better guide the
individualization of therapeutic choices to improve
both efﬁcacy and safety (14).
However, taking advantage of genetic data will
require more than just making the data available.
Nearly three-fourths of physicians report they have
“no to minimal knowledge” of genomics (15), and a
recent study of medical school genetics course di-
rectors found that the majority felt that the genetics
training the students received was inadequate prep-
aration for clinical practice (16). So, for any genomics
data to be actionable, it will likely need to be rein-
forced by substantial efforts in education and auto-
mated clinical decision support.
INTEGRATING DIGITAL TECHNOLOGIES. For many
of the current phenotypic categories of diseases, a
more complete understanding of interindividual
variation in the character and extent of expression of
signs and symptoms could substantially reﬁne di-
agnoses, and likely treatments. Full integration of
digital technologies can help accomplish this in
several ways. Through longitudinal and searchable
EHRs, an extensive and diverse library of unique
characteristics of patients carrying the same diag-
nosis can be created to allow for clinically important
subclassiﬁcations. For example, a recent study of
nearly 400 individuals with a diagnosis of heart fail-
ure with preserved ejection fraction who underwent
detailed clinical, laboratory, ECG, and echocardio-
graphic phenotyping found that patients could be
classiﬁed into 3 distinct groups with an over 4-fold
difference in the risk of hospitalization or death
(Figure 1) (17).
Possibly the most revolutionary, exciting, and
challenging changes to come tomedicine over the nextfew years will be the emergence of a wide selection of
medical-grade wearable sensors that will allow real-
time biometric data tracking of a wide range of phys-
iological parameters. These technologies will allow
hospital-quality monitoring to be performed continu-
ously, with nonobtrusive devices, from the home.
Cardiovascular-focused mobile health technologies
will be particularly common, with devices that can
measure BP without a cuff (even continuously),
patches and shirts that provide continuous multilead
ECG monitoring, noninvasive wearables tracking
transthoracic impedance and cardiac output (also
continuously), and smartphone-based ECGs for
rhythm detection whenever needed (18).
The excessively expansive phenotype of essential
hypertension is a great example of how continuous
(beat-to-beat) monitoring can help identify clinically
important subcategories of patients. A wide vari-
ability in nocturnal BP among patients has been well
described, with 52% of an untreated population being
“dippers,” 8.8% “extreme dippers,” 35% “non-
dippers,” and 6% “risers” (19). In addition, there is
compelling evidence that nocturnal BP is one of the
stronger predictors of CV events, even when con-
trolling for clinical BP (20). Of course, these data come
from limited ambulatory BP monitoring, which is al-
ways challenging to acquire. But with a nonobtrusive,
wearable device, such as a watch, monitoring beat-to-
beat BP continuously, day and night, could become
simple and routine (21) (Figure 2). Not only would
such technology allow a much greater understanding
of nocturnal variation in BP in both known and
unknown hypertensive patients, but the clinical
importance of situational variability in BP could also
be established (22).
These examples are early evidence that wearable
sensors provide much more than just increased con-
venience for replicating what is currently done within
clinics and hospitals. Rather, they offer the potential
to not only reﬁne, but also to completely redeﬁne our
current understanding of many pathophysiological
states. With that understanding will come the ability
to better individualize therapies if and when they are
needed.
IMPROVING PHYSICIAN CARE
According to the Centers for Disease Control and
Prevention (23), just over 611,000 patients died of
heart disease and almost 585,000 died of cancer in
2013 (the latest available statistics). A study pub-
lished that same year estimated that more than
400,000 patients die annually due to preventable
harm in the hospital, making it the third leading
CENTRAL ILLUSTRATION The Digitized Cardiovascular Physician Visit
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1
Steinhubl, S.R. et al. J Am Coll Cardiol. 2015; 66(13):1489–96.
Summarized long-term sensor data presented via tablet computer, pocket ultrasound, handheld electrocardiogram (ECG) acquisition, clinical decision
support, and automated progress note development can all be components.
Steinhubl and Topol J A C C V O L . 6 6 , N O . 1 3 , 2 0 1 5
Digitalization to Digitization S E P T E M B E R 2 9 , 2 0 1 5 : 1 4 8 9 – 9 6
1492cause of death in the United States (24). The inves-
tigator also estimated that the incidence of serious
harm due to preventable errors in the hospital was
10- to 20-fold more common than lethal errors.
Outpatient errors do not appear to be any less
frequent than inpatient errors (25), with 1 study
estimating that 1 in 20 U.S. adults is affected by an
outpatient diagnostic error every year (26). Beyond
these errors of commission are those of omission. A
RAND study of more than 7,400 adults evaluating 439
indicators of care quality for 30 conditions found that
participants received only 54.9% of recommended
care (27). These ﬁgures highlight both the complexity
of patient care and how variable decision making can
be among health care providers. In addition, they
emphasize the critical importance (truly life or death)
of minimizing this complexity and optimizing
decision-making through reducing variability with
evidence-based guidance.
THE CHALLENGE OF COMPLEXITY IN INTENSIVE
CARE. Complexity is greatest in the intensive care
unit, where in an average-size intensive care unit of
6 individuals, there are an average of 178 activitiesper patient every day, meaning more than 1,000 ac-
tivities per day, all with potential for error (28). Novel
technologies, such as wireless, wearable sensors
that continuously track all vital signs, as well as
technologies that allow inpatient data and real-time
monitored information to be viewed on smart-
phones and tablets, can allow better surveillance and
greater access to the data, and therefore more timely
decisions (18). But increasing the deluge of data that
caregivers need to deal with is more likely to increase,
rather than decrease errors through the sheer volume
of noisy information. However, by incorporating
predictive analytic engines that are always running in
the background, the power of these multiple data
streams and how they interact with each other can be
harnessed to provide automated clinical decision
support, improve care, and potentially save lives (29–
31). These tools will not replace, but rather will
empower physicians to perform their jobs more
effectively.
DECISION SUPPORT IN OUTPATIENT CARE. Outpatient
care comes with its own unique challenges, often
driven by a lack of adequate time brought on
FIGURE 1 An Example of Clinically Important Subclassiﬁcation of Phenotypes
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Three distinct subgroups developed through phenomapping of detailed clinical data in 397 patients with a diagnosis of heart failure (HF) with
preserved ejection fraction. After adjustment for known risk factors, a patient’s subgroup was signiﬁcantly associated with adverse outcomes.
Data are from Shah et al. (17). CV ¼ cardiovascular.
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1493by excessive patient volumes necessitated by a fee-
for-service–dominated reimbursement environment.
Studies have found that clinicians have clinically
relevant questions, such as “What is the drug of choice
for this condition?” or “What is the cause of this
symptom?” a little more than once for every
2 patients they see (32). On average, the answers to
those questions were pursued only half the time, and,
in those instances, answers were found 78% of the
time. This suggests that when a clinician has a ques-
tion as to how to best treat a patient at the point of
care, almost two-thirds of the time that question is
never answered. In an age when virtually limitless
information is available, literally, at our ﬁngertips, the
information-intense ﬁeld of health care should have
been one of the ﬁrst to take advantage of cognitive
computing capabilities, rather than a laggard.
Extensive incorporation of automated evidence-
based clinical decision support as a standard compo-
nent of EHRs could eliminate most unanswered
clinical questions, as well as much of the variability in
practice. But it is not yet that straightforward. For
example, in a study of automated stroke and bleeding
risk determination for patients with atrial ﬁbrillation,
although the decision support tool in this studyrecommended warfarin 49% of the time, it was only
utilized in 10% of the patients (33). This suggests
either that clinicians have a way to go to feel
comfortable trusting automated support, or that al-
gorithms are not yet able to capture many nuances of
clinical decision-making. Automated clinical decision
support is far from perfect, but early studies found
that it improves practitioner performance two-thirds
of the time (34). As more data are capable of being
gathered and more data resources incorporated,
automated support will be able to become more
personalized, more accurate, and more effective at
improving physician care.
THE IMPOSSIBILITY OF STAYING CURRENT. As
touched on earlier, physicians’ time is extremely
limited and dominated by the demands of patient
care and associated administrative duties. Yet we
expect to remain state of the art throughout our ca-
reers, and our patients also expect this of us. With
roughly 1 million new, peer-reviewed articles pub-
lished and indexed annually on PubMed, staying on
top of the literature is, in fact, impossible (35). Even if
one were to assume that we need to read and un-
derstand a mere 0.1% of the new medical literature
FIGURE 2 Example of a Wrist-Wearable Multiparametric Sensor
An early prototype of the Quanttus device measures multiple physiological parameters,
including continuous beat-to-beat blood pressure. It is currently being evaluated in clinical
studies. Photo courtesy of Dr. Maulik Majmudar, Chief Clinical Ofﬁcer, Quanttus.
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approximately 20 articles per week. The impossibility
of staying current in practice is reﬂected in the nearly
generational (17 years) delay between a deﬁnitive
clinical trial and changing the majority of clinical
practice (36). Even something as life-saving, safe,
inexpensive, and simple as aspirin in the setting of
an acute myocardial infarction was still not given to
1 of every 4 people admitted to the hospital with
a ST-segment elevation myocardial infarction a full
9 years after the publication of ISIS-2 (Second Inter-
national Study of Infarct Survival) in 1987 (37).
Accepting that we cannot possibly stay current is the
ﬁrst step toward fully embracing the potential of
digital technology to improve the quality of care we
can provide.
The performance of IBM’s Watson on the television
show Jeopardy gives a hint of what modern-day
cognitive computing power can bring to health care.
Watson and similar systems are capable of storing
and instantaneously retrieving enormous amounts of
information. Watson has “read” all of PubMed, can
understand natural language, and can determine the
strength of the hypotheses it generates (38). It will not
be long before physicians will be able to routinely
consult the artiﬁcial intelligence of a Watson for
immediate access to the most up-to-date medical
information and guidance. The ability to take
advantage of resources like this will allow for
more evidence-based, error-free, and intellectually
satisfying interactions with our patients.WHAT WILL DIGITIZATION MEAN?
A major concern of clinicians is that increased use
of technology will damage the doctor-patient rela-
tionship, and with it professional satisfaction. A
recent survey of over 20,000 U.S. physicians tells an
already discouraging story of the current state of
professional satisfaction (39). At least one-half of the
respondents described their morale as negative,
considered themselves pessimistic about the future
of medicine, and would not recommend health care
as a profession to their children. Reinforcing the
importance of our interactions with patients, the
vast majority of respondents (78.6%) felt that their
relationships with their patients were the most
satisfying aspect of their practice. Rather than
harm this, we believe that the digitization of health
care can eventually help build a markedly improved
physician-patient relationships, allowing greater
time for interaction when a patient requires the care
of a physician. This is because when care is bolstered
by digital technologies that better individualize dia-
gnostics and treatments, simplify real-world moni-
toring, and provide evidence-based guidance at
the point of need, then much of what physicians
currently spend their time doing can be handled
through automated systems or by others in the care
team, maintaining the physician’s time to serve pri-
marily as a diagnostician and educator. Furthermore,
the increased reliance on patient-generated data,
with direct feedback to the patient, will lead to
marked increases in engagement.
SYNERGIZING HUMAN AND ARTIFICIAL INTELLIGENCE
Although ever-increasing computational power,
ubiquitous connectivity, and continually shrinking
high-ﬁdelity sensors are a powerful set of tools,
there will always be a need for the expertise and,
especially, the compassion of a clinician: someone
with the skills of a diagnostician and educator,
and with the ability (and time) to synthesize mul-
tiple complicated inputs, act on, and explain
them. The artiﬁcial intelligence that prodigious
computational power brings does not replace
human intellect. Rather, it complements and re-
inforces it.
An example comes from the world of chess,
which was the ﬁrst real test of human intellect
versus machine. In 1997 IBM’s Deep Blue beat the
reigning chess grandmaster Garry Kasparov, a
tremendous feat of computational capability for the
time. Today, however, in freestyle chess matches
where anything is allowed—man alone, machine
alone, or man plus machine— the combination of
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quent winner (40).
Another example of how the synergy of human
intellect plus computer support is better than either
alone is in weather forecasting. Predicting the weather
requires analyzing numerous streams of disparate, but
potentially related data from a plethora of sensors.
Weather prediction is aided by the National Center for
Atmospheric Research supercomputer, which is
capable of 77 trillion calculations per second. Thanks
to the ability of the supercomputer to model weather
patterns, the accuracy of hurricane forecasting has
improved 350% over the last 25 years (41). Yet, ac-
cording to theNationalWeather Service,whenhumans
interact with the computer models, they improve
precipitation forecasts by 25% and temperatureforecasts by 10% compared with the computer model
alone (41).
As the era of big data per individual comes
into play, with terabytes of biological, anatomic,
physiological, and environmental data becoming
fully integrated, humans will no longer be capable of
processing the information. This requires synergistic
interaction between man and machine, which ulti-
mately will transform medicine into a digitized data
science and, in the process, markedly improve health
care.
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